Literature DB >> 8520802

Evaluation of Dirofilaria immitis excretory/secretory products for seroepidemiological studies on human dirofilariosis.

B Santamaría1, M Cordero, A Muro, F Simón.   

Abstract

The usefulness of excretory/secretory (E/S) products of adult Dirofilaria immitis for the diagnosis of human dirofilariosis was evaluated in 97 human sera using an ELISA and a Western Blot analysis with E/S antigens. Results of the ELISA analysis show that in healthy individuals from an endemic area seropositivity is high (22%). Immuno Blot analysis shows that the reaction pattern with E/S antigens differentiates healthy seropositives, which recognize a 43 kDa band, from patients with pulmonary dirofilariosis, which specifically recognize bands between 22-28 kDa.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520802     DOI: 10.1051/parasite/1995023269

Source DB:  PubMed          Journal:  Parasite        ISSN: 1252-607X            Impact factor:   3.000


  4 in total

Review 1.  Zoonotic filariasis.

Authors:  T C Orihel; M L Eberhard
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 2.  Human Dirofilaria repens infections diagnosed in Slovakia in the last 10 years (2007-2017).

Authors:  Martina Miterpáková; Daniela Antolová; František Ondriska; Viliam Gál
Journal:  Wien Klin Wochenschr       Date:  2017-07-21       Impact factor: 1.704

Review 3.  Human and animal dirofilariasis: the emergence of a zoonotic mosaic.

Authors:  Fernando Simón; Mar Siles-Lucas; Rodrigo Morchón; Javier González-Miguel; Isabel Mellado; Elena Carretón; Jose Alberto Montoya-Alonso
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

4.  Seroreactivity to Dirofilaria antigens in people from different areas of Serbia.

Authors:  Suzana A Tasić-Otašević; Simona V Gabrielli; Aleksandar V Tasić; Nataša L Miladinovićtasić; Jovana T Kostić; Aleksandra M Ignjatović; Lidija D Popović Dragonjić; Zoran G Milošević; Valentina S Arsić-Arsenijević; Gabriella A Cancrini
Journal:  BMC Infect Dis       Date:  2014-02-08       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.